Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | IDO1 | P14902 | 1/20 | 0.58 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MTOR | P42345 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.53 |
| ▸ | MMP1 | P03956 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL27899663 | 0.93 | MEN1 (0.59) | MEN1KMT2ARAB9ATSHRHPGD | |
| Malonic Acid SCHEMBL27899662 | 0.91 | MEN1 (0.62) | MEN1KMT2ARAB9ATSHRHPGD | |
| SCHEMBL27899660 | 0.91 | KMT2A (0.57) | MEN1KMT2ARAB9ATSHRHPGD | |
| Nitric Acid SCHEMBL3442027 | 0.90 | MEN1 (0.56) | MEN1KMT2ARAB9ATSHRHPGD | |
| Maleic Acid SCHEMBL27899766 | 0.90 | MMP1 (0.56) | MEN1KMT2ARAB9ATSHRHPGD | |
| Trifluoroacetic Acid SCHEMBL6506840 | 0.90 | CHIT1 (0.57) | MEN1KMT2ARAB9ATSHRHPGD | |
| Cadaverine Tartrate SCHEMBL27917346 | 0.88 | MEN1 (0.54) | MEN1KMT2ARAB9ATSHRHPGD | |
| SCHEMBL3690365 | 0.85 | MAPT (0.59) | MEN1KMT2ANPC1ALDH1A1MAPT | |
| SCHEMBL13906101 | 0.85 | MEN1 (0.62) | MEN1KMT2ARAB9ATSHRHPGD | |
| SCHEMBL30851500 | 0.83 | RAB9A (0.79) | MEN1KMT2ARAB9ATSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025122121-A2 | COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND THE METHOD OF OBTAINING THESE COMPOUNDS | HACETTEPE UNIVERSITESI REKTORLUK (TR) | 2025-06-12 | — | — | WO | claimed |
| US-20240262801-A1 | COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES | MONDEGO BIO, LDA. (PT) | 2024-08-08 | — | — | US | claimed |
| CN-111526877-B | Compounds and compositions for IRE1 inhibition | 奥普提卡拉公司 | 2023-08-25 | — | — | CN | claimed |
| CN-104902895-B | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | 德西费拉制药有限责任公司 | 2019-03-29 | — | — | CN | claimed |
| EP-3119937-B1 | METHOD FOR COLOURING CELLULOSE | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2018-05-16 | — | — | EP | claimed |
| US-20170096773-A1 | METHOD FOR COLORING CELLULOSE | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-04-06 | — | — | US | claimed |
| EP-3119937-A1 | METHOD FOR COLOURING CELLULOSE | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2017-01-25 | — | — | EP | claimed |
| US-9198426-B2 | Use of 5 pyridin-4-yl-1,3-thiazoles for controlling phytopathogenic fungi | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-12-01 | — | — | US | claimed |
| WO-2015157360-A1 | PROCESSES TO MAKE PROTEIN KINASE INHIBITORS | ABBVIE INC. (US) | 2015-10-15 | — | — | WO | claimed |
| WO-2015140750-A1 | METHOD FOR COLOURING CELLULOSE | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-09-24 | — | — | WO | claimed |
| CN-101048383-A | Gonadotropin releasing hormone receptor antagonists | WYETH CORP (US) | 2007-10-03 | — | — | CN | claimed |
| CN-1942475-A | Substituted thieno - and thiazolo - [2, 3-d] pyridines as inhibitors of Tie2 | ASTRAZENECA AB (SE) | 2007-04-04 | — | — | CN | claimed |
| EP-1737830-A1 | TRI-SUBSTITUTED UREAS AS CYTOKINE INHIBITORS | The Procter and Gamble Company (US) | 2007-01-03 | — | — | EP | claimed |
| WO-2005105757-A1 | TRI-SUBSTITUTED UREAS AS CYTOKINE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2005-11-10 | — | — | WO | claimed |
| CN-1181070-C | Urea substituted imidazoquinolines | 3M | 2004-12-22 | — | — | CN | claimed |
| CN-1355701-A | Urea substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES CO (US) | 2002-06-26 | — | — | CN | claimed |
| EP-1124811-A1 | 2-UREIDO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS | PHARMACIA & UPJOHN S.p.A. (IT) | 2001-08-22 | — | — | EP | claimed |
| WO-2000026203-A1 | 2-UREIDO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS | PHARMACIA & UPJOHN S.P.A. (IT) | 2000-05-11 | — | — | WO | claimed |
| US-5696110-A | ANTIULCER AGENTS | MERCK, SHARP & DOHME, LTD. (GB) | 1997-12-09 | — | — | US | claimed |
| EP-0652871-A1 | BENZODIAZEPINE DERIVATIVES | MERCK SHARP & DOHME LTD. (GB) | 1995-05-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240262801-A1 | COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES | PPM1A, TH, PPM1G | MEN1 2523/4885KMT2A 1362/4885RAB9A 2110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.